346
Views
29
CrossRef citations to date
0
Altmetric
Review

Biomarkers of multiple sclerosis: current findings

, &
Pages 19-29 | Published online: 12 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mehdi Khorrami, Maryam Saneipour, Abbas Moridnia, Vahid Shaygannejad, Erfan Sadeghi, Aziz Kassani, Akram Sarmadi & Omid Mirmosayyeb. (2022) Interdependency of NINJ2 gene expression and polymorphism with susceptibility and response to interferon beta in patients with multiple sclerosis. International Journal of Neuroscience 0:0, pages 1-6.
Read now
Samar A. Zailaie, Jumana Jamal Siddiqui, Rawan Mansour Al Saadi, Dalia Mohammad Anbari, Amani S. Alomari & Edward James Cupler. (2022) Serum Based miRNA as a Diagnostic Biomarker for Multiple Sclerosis: a Systematic Review and Meta-Analysis. Immunological Investigations 51:4, pages 947-962.
Read now
Laisheng Cai & Jingwei Huang. (2018) Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study. Neuropsychiatric Disease and Treatment 14, pages 2241-2254.
Read now

Articles from other publishers (26)

Angela Maria Di Francesco, Elena Verrecchia, Stefano Manna, Andrea Urbani & Raffaele Manna. (2023) The chitinases as biomarkers in immune-mediate diseases. Clinical Chemistry and Laboratory Medicine (CCLM) 61:8, pages 1363-1381.
Crossref
Özkan Alataş, Berrin Çavuşoğlu, Ali Çaylak, Onur Keskin, Egemen İdiman, Fethi İdiman & Emel Ada. (2023) Evaluation of Diffusion Tensor Imaging Findings in Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis Patients. Turkish Journal Of Neurology 29:1, pages 40-45.
Crossref
Anne-Sophie Dietmann, Niels Kruse, Lidia Stork, Mareike Gloth, Wolfgang Brück & Imke Metz. (2022) Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological–serological correlative study. Journal of Neurology 270:3, pages 1416-1429.
Crossref
Ipek Yavas, Ergi Kaya & Asiye Tuba Ozdogar. (2023) Determining the Prognostic Characteristics of People with Multiple Sclerosis with Bowel and Bladder Dysfunction as the Initial Presentation: A Cohort Study. Journal of Multiple Sclerosis Research 2:3, pages 62-67.
Crossref
Tuba Gökdoğan Edgünlü, Şenay Görücü Yılmaz, Ufuk Emre, Bahar Taşdelen, Oktay Kuru, Gülnihal Kutlu & Mehmet Emin Erdal. (2022) miR-181a-5p is a potential candidate epigenetic biomarker in multiple sclerosis. Genome 65:11, pages 547-561.
Crossref
Qingqing Zhou, Rui Jia & Jingxia Dang. (2022) Correlation between the Neutrophil-to-Lymphocyte Ratio and Multiple Sclerosis: Recent Understanding and Potential Application Perspectives. Neurology Research International 2022, pages 1-10.
Crossref
Nadia Barizzone, Maurizio Leone, Alessandro Pizzino, Ingrid Kockum, Filippo Martinelli-Boneschi & Sandra D’Alfonso. (2022) A Scoping Review on Body Fluid Biomarkers for Prognosis and Disease Activity in Patients with Multiple Sclerosis. Journal of Personalized Medicine 12:9, pages 1430.
Crossref
Jennifer Yang, Maysa Hamade, Qi Wu, Qin Wang, Robert Axtell, Shailendra Giri & Yang Mao-Draayer. (2022) Current and Future Biomarkers in Multiple Sclerosis. International Journal of Molecular Sciences 23:11, pages 5877.
Crossref
Danica Michaličková, Öztürk KübraHaticeHatice, Debanjan Das, Bukhari OsamaSyedSyed & Ondřej Slanař. (2022) Molecular biomarkers in multiple sclerosis. Arhiv za farmaciju 72:2, pages 127-148.
Crossref
Valentina Ignatova. 2022. Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments [Working Title]. Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments [Working Title].
Cory J. Holdom, Frederik J. Steyn, Robert D. Henderson, Pamela A. McCombe, Mary-Louise Rogers & Shyuan T. Ngo. 2022. Neurodegenerative Diseases Biomarkers. Neurodegenerative Diseases Biomarkers 263 306 .
Leire Iparraguirre, Ainhoa Alberro, Thomas B. Hansen, Tamara Castillo-Triviño, Maider Muñoz-Culla & David Otaegui. (2021) Profiling of Plasma Extracellular Vesicle Transcriptome Reveals That circRNAs Are Prevalent and Differ between Multiple Sclerosis Patients and Healthy Controls. Biomedicines 9:12, pages 1850.
Crossref
Patrícia Rodrigues, Guilherme Vargas Bochi & Gabriela Trevisan. (2021) Advanced Oxidative Protein Products Role in Multiple Sclerosis: a Systematic Review and Meta-analysis. Molecular Neurobiology 58:11, pages 5724-5742.
Crossref
Deepali Mathur, Bikash Kumar Mishra, Soumyashree Rout, Francisco Jose Lopez-Iranzo, Gerardo Lopez-Rodas, Jayalakshmi Vallamkondu, Ramesh Kandimalla & Bonaventura Casanova. (2021) Potential Biomarkers Associated with Multiple Sclerosis Pathology. International Journal of Molecular Sciences 22:19, pages 10323.
Crossref
Ferdinanda Annesi, Sonia Hermoso-Durán, Bruno Rizzuti, Rosalinda Bruno, Domenico Pirritano, Alfredo Petrone, Francesco Del Giudice, Jorge Ojeda, Sonia Vega, Oscar Sanchez-Gracia, Adrian Velazquez-Campoy, Olga Abian & Rita Guzzi. (2021) Thermal Liquid Biopsy (TLB) of Blood Plasma as a Potential Tool to Help in the Early Diagnosis of Multiple Sclerosis. Journal of Personalized Medicine 11:4, pages 295.
Crossref
T. P. Ospelnikova & A. D. Shitova. (2021) Possible biomarkers of therapy effective. Russian neurological journal 26:1, pages 4-14.
Crossref
Georgia Mandolesi, Francesca Romana Rizzo, Sara Balletta, Mario Stampanoni Bassi, Luana Gilio, Livia Guadalupi, Monica Nencini, Alessandro Moscatelli, Colleen Patricia Ryan, Valerio Licursi, Ettore Dolcetti, Alessandra Musella, Antonietta Gentile, Diego Fresegna, Silvia Bullitta, Silvia Caioli, Valentina Vanni, Krizia Sanna, Antonio Bruno, Fabio Buttari, Chiara Castelli, Carlo Presutti, Francesca De Santa, Annamaria Finardi, Roberto Furlan, Diego Centonze & Francesca De Vito. (2021) The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis. Cells 10:2, pages 330.
Crossref
Mohammad Arastoo, Richard Lofthouse, Lewis K. Penny, Charles R. Harrington, Andy Porter, Claude M. Wischik & Soumya Palliyil. (2020) Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer’s Disease. International Journal of Molecular Sciences 21:22, pages 8673.
Crossref
Ettore Dolcetti, Antonio Bruno, Livia Guadalupi, Francesca Romana Rizzo, Alessandra Musella, Antonietta Gentile, Francesca De Vito, Silvia Caioli, Silvia Bullitta, Diego Fresegna, Valentina Vanni, Sara Balletta, Krizia Sanna, Fabio Buttari, Mario Stampanoni Bassi, Diego Centonze & Georgia Mandolesi. (2020) Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis. International Journal of Molecular Sciences 21:19, pages 7336.
Crossref
Maryam Gul, Amirhossein Azari Jafari, Muffaqam Shah, Seyyedmohammadsadeq Mirmoeeni, Safee Ullah Haider, Sadia Moinuddin & Ammar Chaudhry. (2020) Molecular Biomarkers in Multiple Sclerosis and Its Related Disorders: A Critical Review. International Journal of Molecular Sciences 21:17, pages 6020.
Crossref
Ghada Al-Kafaji, Halla F. Bakheit, Maram A. Alharbi, Ahmad A. Farahat, Mohamed Jailani, Bashayer H. Ebrahin & Moiz Bakhiet. (2020) Mitochondrial DNA Copy Number in Peripheral Blood as a Potential Non-invasive Biomarker for Multiple Sclerosis. NeuroMolecular Medicine 22:2, pages 304-313.
Crossref
David Haschka, Piotr Tymoszuk, Gabriel Bsteh, Verena Petzer, Klaus Berek, Igor Theurl, Thomas Berger & Günter Weiss. (2020) Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis. Frontiers in Immunology 11.
Crossref
Angela Dziedzic, Elzbieta Miller, Joanna Saluk-Bijak & Michal Bijak. (2020) The GPR17 Receptor—A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis. International Journal of Molecular Sciences 21:5, pages 1852.
Crossref
Carmen Elena Condrat, Dana Claudia Thompson, Madalina Gabriela Barbu, Oana Larisa Bugnar, Andreea Boboc, Dragos Cretoiu, Nicolae Suciu, Sanda Maria Cretoiu & Silviu Cristian Voinea. (2020) miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis. Cells 9:2, pages 276.
Crossref
Bridget Martinez & PhilipV Peplow. (2020) MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression. Neural Regeneration Research 15:4, pages 606.
Crossref
Raffaele Simeoli & Alessandra Fierabracci. (2019) Insights into the Role of MicroRNAs in the Onset and Development of Diabetic Neuropathy. International Journal of Molecular Sciences 20:18, pages 4627.
Crossref